Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.
Show references:
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy )
Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III))
Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE))
Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke)
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com) for more information.
Disclosures can be found at Neurology.org.
